治心脏神经官能症验方

来源 :第五届中国中西医结合学会神经科专业委员会第十二次全国中西医结合神经科学术年会 | 被引量 : 0次 | 上传用户:fmklsdfjds
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
心脏神经官能症是以心血管疾病的有关症状为主要表现的临床综合征,属于功能性神经症的一种类型,又称功能性心脏不适.该病大多发生在中、青年,女性多于男性,尤其是更年期的妇女发病率较高.心脏神经官能症的患者心脏无器质性改变,临床以心脏症状和神经衰弱症状为主.其主要临床表现为呼吸困难(常伴有叹息性呼吸)、心悸、疲乏、心前区隐痛、眩晕、多汗、手足发冷、双手震颤、尿频等.多在劳累或精神紧张后发生或加重.本病属中医学中"惊悸""不寐""虚劳"等范畴.并重点介绍了治疗该病的验方.
其他文献
目的:探讨白术内酯Ⅰ抑制卵巢癌SK-OV-3与OVCAR-3细胞增殖的作用及其分子机制.方法:MTT实验检测不同浓度白术内酯Ⅰ作用人卵巢癌SK-OV-3与OVCAR-3细胞24h、48h与72h后,白术内酯Ⅰ对卵巢癌细胞增殖的影响;流式细胞技术与PI染色检测白术内酯Ⅰ对卵巢癌SK-OV-3与OVCAR-3细胞周期的影响,ELISA实验检测白术内酯Ⅰ对卵巢癌SK-OV-3与OVCAR-3细胞cycl
Background Mineralocorticoid receptor antagonists (MRAs) are used widely in treatment of heart failure, but their effects on cardiovascular complications and mortality of chronic kidney disease (CKD)
Objective Radix salviae miltiorrhizae (SM) and Lignum dalbergiae odoriferae (DO) are both traditional Chinese medicinal herbs for the treatment of ischemic heart disease and other cardiovascular disea
抗微管天然产物Combretastatin A-4 (CA-4)能快速、选择性地破坏新生的肿瘤血管,短时间内阻断肿瘤血流供应,引起肿瘤细胞的二重死亡,导致肿瘤细胞坏死.由于其作用机制的新颖性以及结构的独特性,近十几年引起广泛的研究.新型小分子微管抑制剂IMB-105是以CA-4为模板,得到的具有全新分子骨架结构的化合物,它表现出很好的体内外抗肿瘤活性,尤其是对肝癌、乳腺癌等,而且毒副作用小,但因其
OBJECTIVE To explore the optimal ultrasonic-assisted process and increase the yield of alkaloids from Piper longum L..METHODS Optimal ultrasound-assisted extraction (UAE) process of alkaloids from P l
A series of novel dipeptidyl boronic acid proteasome inhibitors constructed from αα-and αβ-amino acids were designed and synthesized.Their structures were elucidated by 1H NMR,13C NMR, LC-MS and HRMS.
Objective This study is aimed at seeking a nature saponin-based stabilizer for production of drug nanosuspensions.A poorly soluble drug (andrographolide, Andro) was used as a model drug.Andro nanosusp
A novel and efficient preparation of epoxyketone intermediates for the synthesis of carfilzomib and its derivatives has been developed.Compared to reported methods, this highly stereoselective, enviro
目的:埃博拉病毒(EBOV)引发的急性传染病在全球时有发生,患者临床表现主要为发热、出血、多脏器受损和低血压,病死率高达90%.虽然WHO于2016年1月14日宣布西非呈现零EBOV感染病例,但于1月15日又确认一起新发病例,这表明该病毒依然存在新病例的突发危险或者耐药新EBOV的出现,人类与EBOV烈性病原是一场持久战.因此,如何有效的控制其继续流行及未来可能的大流行,成为了全人类面临的严重的社
Proteasome had been clinically validated as an effective target for the treatment of cancers.The high selectivity and low dissociation rates of boronic acids have placed these chemical compounds into